Global Anti-Peptic Ulcer Drugs Market Insights and Forecast to 2027

Global Anti-Peptic Ulcer Drugs Market Insights and Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Anti-Peptic Ulcer Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Anti-Peptic Ulcer Drugs Market Size Growth Rate by Type
1.4.2 Proton Pump Inhibitors (PPIs)
1.4.3 Potassium-Competitive Acid Blockers (P-CAB)
1.2.4 Antacids
1.2.5 H2 Antagonists
1.2.6 Ulcer Protective Drugs
1.3 Market by Application
1.3.1 Global Anti-Peptic Ulcer Drugs Market Size Growth Rate by Application
1.3.2 Gastritis
1.3.3 Gastric Ulcers
1.3.4 Duodenal Ulcers
1.3.5 Gastroesophageal Reflux Disease (GERD)
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Anti-Peptic Ulcer Drugs Sales Estimates and Forecasts 2016-2027
2.2 Global Anti-Peptic Ulcer Drugs Revenue Estimates and Forecasts 2016-2027
2.3 Global Anti-Peptic Ulcer Drugs Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Anti-Peptic Ulcer Drugs Regions by Sales
2.4.1 Global Top Anti-Peptic Ulcer Drugs Regions by Sales (2016-2021)
2.4.2 Global Top Anti-Peptic Ulcer Drugs Regions by Sales (2022-2027)
2.5 Global Top Anti-Peptic Ulcer Drugs Regions by Revenue
2.5.1 Global Top Anti-Peptic Ulcer Drugs Regions by Revenue (2016-2021)
2.5.2 Global Top Anti-Peptic Ulcer Drugs Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Anti-Peptic Ulcer Drugs Sales by Manufacturers
3.1.1 Global Top Anti-Peptic Ulcer Drugs Manufacturers by Sales (2016-2021)
3.1.2 Global Top Anti-Peptic Ulcer Drugs Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Anti-Peptic Ulcer Drugs Sales in 2020
3.2 Global Anti-Peptic Ulcer Drugs Revenue by Manufacturers
3.2.1 Global Top Anti-Peptic Ulcer Drugs Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Anti-Peptic Ulcer Drugs Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Anti-Peptic Ulcer Drugs Revenue in 2020
3.3 Global Anti-Peptic Ulcer Drugs Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Anti-Peptic Ulcer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Anti-Peptic Ulcer Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Anti-Peptic Ulcer Drugs Sales by Type
4.1.1 Global Anti-Peptic Ulcer Drugs Historical Sales by Type (2016-2021)
4.1.2 Global Anti-Peptic Ulcer Drugs Forecasted Sales by Type (2022-2027)
4.1.3 Global Anti-Peptic Ulcer Drugs Sales Market Share by Type (2016-2027)
4.2 Global Anti-Peptic Ulcer Drugs Revenue by Type
4.2.1 Global Anti-Peptic Ulcer Drugs Historical Revenue by Type (2016-2021)
4.2.2 Global Anti-Peptic Ulcer Drugs Forecasted Revenue by Type (2022-2027)
4.2.3 Global Anti-Peptic Ulcer Drugs Revenue Market Share by Type (2016-2027)
4.3 Global Anti-Peptic Ulcer Drugs Price by Type
4.3.1 Global Anti-Peptic Ulcer Drugs Price by Type (2016-2021)
4.3.2 Global Anti-Peptic Ulcer Drugs Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Anti-Peptic Ulcer Drugs Sales by Application
5.1.1 Global Anti-Peptic Ulcer Drugs Historical Sales by Application (2016-2021)
5.1.2 Global Anti-Peptic Ulcer Drugs Forecasted Sales by Application (2022-2027)
5.1.3 Global Anti-Peptic Ulcer Drugs Sales Market Share by Application (2016-2027)
5.2 Global Anti-Peptic Ulcer Drugs Revenue by Application
5.2.1 Global Anti-Peptic Ulcer Drugs Historical Revenue by Application (2016-2021)
5.2.2 Global Anti-Peptic Ulcer Drugs Forecasted Revenue by Application (2022-2027)
5.2.3 Global Anti-Peptic Ulcer Drugs Revenue Market Share by Application (2016-2027)
5.3 Global Anti-Peptic Ulcer Drugs Price by Application
5.3.1 Global Anti-Peptic Ulcer Drugs Price by Application (2016-2021)
5.3.2 Global Anti-Peptic Ulcer Drugs Price Forecast by Application (2022-2027)
6 North America
6.1 North America Anti-Peptic Ulcer Drugs Market Size by Type
6.1.1 North America Anti-Peptic Ulcer Drugs Sales by Type (2016-2027)
6.1.2 North America Anti-Peptic Ulcer Drugs Revenue by Type (2016-2027)
6.2 North America Anti-Peptic Ulcer Drugs Market Size by Application
6.2.1 North America Anti-Peptic Ulcer Drugs Sales by Application (2016-2027)
6.2.2 North America Anti-Peptic Ulcer Drugs Revenue by Application (2016-2027)
6.3 North America Anti-Peptic Ulcer Drugs Market Size by Country
6.3.1 North America Anti-Peptic Ulcer Drugs Sales by Country (2016-2027)
6.3.2 North America Anti-Peptic Ulcer Drugs Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Anti-Peptic Ulcer Drugs Market Size by Type
7.1.1 Europe Anti-Peptic Ulcer Drugs Sales by Type (2017-2027)
7.1.2 Europe Anti-Peptic Ulcer Drugs Revenue by Type (2017-2027)
7.2 Europe Anti-Peptic Ulcer Drugs Market Size by Application
7.2.1 Europe Anti-Peptic Ulcer Drugs Sales by Application (2017-2027)
7.2.2 Europe Anti-Peptic Ulcer Drugs Revenue by Application (2017-2027)
7.3 Europe Anti-Peptic Ulcer Drugs Market Size by Country
7.3.1 Europe Anti-Peptic Ulcer Drugs Sales by Country (2017-2027)
7.3.2 Europe Anti-Peptic Ulcer Drugs Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Anti-Peptic Ulcer Drugs Market Size by Type
8.1.1 Asia Pacific Anti-Peptic Ulcer Drugs Sales by Type (2018-2027)
8.1.2 Asia Pacific Anti-Peptic Ulcer Drugs Revenue by Type (2018-2027)
8.2 Asia Pacific Anti-Peptic Ulcer Drugs Market Size by Application
8.2.1 Asia Pacific Anti-Peptic Ulcer Drugs Sales by Application (2018-2027)
8.2.2 Asia Pacific Anti-Peptic Ulcer Drugs Revenue by Application (2018-2027)
8.3 Asia Pacific Anti-Peptic Ulcer Drugs Market Size by Region
8.3.1 Asia Pacific Anti-Peptic Ulcer Drugs Sales by Region (2018-2027)
8.3.2 Asia Pacific Anti-Peptic Ulcer Drugs Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Anti-Peptic Ulcer Drugs Market Size by Type
9.1.1 Latin America Anti-Peptic Ulcer Drugs Sales by Type (2019-2027)
9.1.2 Latin America Anti-Peptic Ulcer Drugs Revenue by Type (2019-2027)
9.2 Latin America Anti-Peptic Ulcer Drugs Market Size by Application
9.2.1 Latin America Anti-Peptic Ulcer Drugs Sales by Application (2019-2027)
9.2.2 Latin America Anti-Peptic Ulcer Drugs Revenue by Application (2019-2027)
9.3 Latin America Anti-Peptic Ulcer Drugs Market Size by Country
9.3.1 Latin America Anti-Peptic Ulcer Drugs Sales by Country (2019-2027)
9.3.2 Latin America Anti-Peptic Ulcer Drugs Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Anti-Peptic Ulcer Drugs Market Size by Type
6.1.1 Middle East and Africa Anti-Peptic Ulcer Drugs Sales by Type (2016-2027)
6.1.2 Middle East and Africa Anti-Peptic Ulcer Drugs Revenue by Type (2016-2027)
6.2 Middle East and Africa Anti-Peptic Ulcer Drugs Market Size by Application
6.2.1 Middle East and Africa Anti-Peptic Ulcer Drugs Sales by Application (2016-2027)
6.2.2 Middle East and Africa Anti-Peptic Ulcer Drugs Revenue by Application (2016-2027)
6.3 Middle East and Africa Anti-Peptic Ulcer Drugs Market Size by Country
6.3.1 Middle East and Africa Anti-Peptic Ulcer Drugs Sales by Country (2016-2027)
6.3.2 Middle East and Africa Anti-Peptic Ulcer Drugs Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Overview
11.1.3 AstraZeneca Anti-Peptic Ulcer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 AstraZeneca Anti-Peptic Ulcer Drugs Product Description
11.1.5 AstraZeneca Related Developments
11.2 Ask-pharm
11.2.1 Ask-pharm Corporation Information
11.2.2 Ask-pharm Overview
11.2.3 Ask-pharm Anti-Peptic Ulcer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Ask-pharm Anti-Peptic Ulcer Drugs Product Description
11.2.5 Ask-pharm Related Developments
11.3 Takeda
11.3.1 Takeda Corporation Information
11.3.2 Takeda Overview
11.3.3 Takeda Anti-Peptic Ulcer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Takeda Anti-Peptic Ulcer Drugs Product Description
11.3.5 Takeda Related Developments
11.4 Yangtze River Pharm
11.4.1 Yangtze River Pharm Corporation Information
11.4.2 Yangtze River Pharm Overview
11.4.3 Yangtze River Pharm Anti-Peptic Ulcer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Yangtze River Pharm Anti-Peptic Ulcer Drugs Product Description
11.4.5 Yangtze River Pharm Related Developments
11.5 Shandong Luoxin
11.5.1 Shandong Luoxin Corporation Information
11.5.2 Shandong Luoxin Overview
11.5.3 Shandong Luoxin Anti-Peptic Ulcer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Shandong Luoxin Anti-Peptic Ulcer Drugs Product Description
11.5.5 Shandong Luoxin Related Developments
11.6 Huadong Medicine
11.6.1 Huadong Medicine Corporation Information
11.6.2 Huadong Medicine Overview
11.6.3 Huadong Medicine Anti-Peptic Ulcer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Huadong Medicine Anti-Peptic Ulcer Drugs Product Description
11.6.5 Huadong Medicine Related Developments
11.7 Changzhou Siyao
11.7.1 Changzhou Siyao Corporation Information
11.7.2 Changzhou Siyao Overview
11.7.3 Changzhou Siyao Anti-Peptic Ulcer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Changzhou Siyao Anti-Peptic Ulcer Drugs Product Description
11.7.5 Changzhou Siyao Related Developments
11.8 Beijing Yuekang
11.8.1 Beijing Yuekang Corporation Information
11.8.2 Beijing Yuekang Overview
11.8.3 Beijing Yuekang Anti-Peptic Ulcer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Beijing Yuekang Anti-Peptic Ulcer Drugs Product Description
11.8.5 Beijing Yuekang Related Developments
11.9 Guangdong Dahua
11.9.1 Guangdong Dahua Corporation Information
11.9.2 Guangdong Dahua Overview
11.9.3 Guangdong Dahua Anti-Peptic Ulcer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Guangdong Dahua Anti-Peptic Ulcer Drugs Product Description
11.9.5 Guangdong Dahua Related Developments
11.10 Xian Janssen
11.10.1 Xian Janssen Corporation Information
11.10.2 Xian Janssen Overview
11.10.3 Xian Janssen Anti-Peptic Ulcer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Xian Janssen Anti-Peptic Ulcer Drugs Product Description
11.10.5 Xian Janssen Related Developments
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Overview
11.1.3 AstraZeneca Anti-Peptic Ulcer Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 AstraZeneca Anti-Peptic Ulcer Drugs Product Description
11.1.5 AstraZeneca Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Anti-Peptic Ulcer Drugs Value Chain Analysis
12.2 Anti-Peptic Ulcer Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anti-Peptic Ulcer Drugs Production Mode & Process
12.4 Anti-Peptic Ulcer Drugs Sales and Marketing
12.4.1 Anti-Peptic Ulcer Drugs Sales Channels
12.4.2 Anti-Peptic Ulcer Drugs Distributors
12.5 Anti-Peptic Ulcer Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Anti-Peptic Ulcer Drugs Industry Trends
13.2 Anti-Peptic Ulcer Drugs Market Drivers
13.3 Anti-Peptic Ulcer Drugs Market Challenges
13.4 Anti-Peptic Ulcer Drugs Market Restraints
14 Key Findings in The Global Anti-Peptic Ulcer Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Anti-Peptic Ulcer Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Proton Pump Inhibitors (PPIs)
Table 3. Major Manufacturers of Potassium-Competitive Acid Blockers (P-CAB)
Table 4. Major Manufacturers of Antacids
Table 5. Major Manufacturers of H2 Antagonists
Table 6. Major Manufacturers of Ulcer Protective Drugs
Table 7. Global Anti-Peptic Ulcer Drugs Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 8. Global Anti-Peptic Ulcer Drugs Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 9. Global Anti-Peptic Ulcer Drugs Sales by Region (2016-2021) & (K MT)
Table 10. Global Anti-Peptic Ulcer Drugs Sales Market Share by Region (2016-2021)
Table 11. Global Anti-Peptic Ulcer Drugs Sales by Region (2016-2021) & (K MT)
Table 12. Global Anti-Peptic Ulcer Drugs Sales Market Share by Region (2022-2027)
Table 13. Global Anti-Peptic Ulcer Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 14. Global Anti-Peptic Ulcer Drugs Revenue Market Share by Region (2016-2021)
Table 15. Global Anti-Peptic Ulcer Drugs Revenue by Region (2022-2027) & (US$ Million)
Table 16. Global Anti-Peptic Ulcer Drugs Revenue Market Share by Region (2022-2027)
Table 17. Global Anti-Peptic Ulcer Drugs Sales by Manufacturers (2016-2021) & (K MT)
Table 18. Global Anti-Peptic Ulcer Drugs Sales Share by Manufacturers (2016-2021)
Table 19. Global Anti-Peptic Ulcer Drugs Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 20. Global Anti-Peptic Ulcer Drugs Revenue Share by Manufacturers (2016-2021)
Table 21. Anti-Peptic Ulcer Drugs Price by Manufacturers 2016-2021 (USD/MT)
Table 22. Global Anti-Peptic Ulcer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Anti-Peptic Ulcer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Peptic Ulcer Drugs as of 2020)
Table 24. Anti-Peptic Ulcer Drugs Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Anti-Peptic Ulcer Drugs Product Offered
Table 26. Date of Manufacturers Enter into Anti-Peptic Ulcer Drugs Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Anti-Peptic Ulcer Drugs Sales by Type (2016-2021) & (K MT)
Table 29. Global Anti-Peptic Ulcer Drugs Sales by Type (2022-2027) & (K MT)
Table 30. Global Anti-Peptic Ulcer Drugs Sales Share by Type (2016-2021)
Table 31. Global Anti-Peptic Ulcer Drugs Sales Share by Type (2022-2027)
Table 32. Global Anti-Peptic Ulcer Drugs Revenue by Type (2016-2021) & (US$ Million)
Table 33. Global Anti-Peptic Ulcer Drugs Revenue by Type (2022-2027) & (US$ Million)
Table 34. Global Anti-Peptic Ulcer Drugs Revenue Share by Type (2016-2021)
Table 35. Global Anti-Peptic Ulcer Drugs Revenue Share by Type (2022-2027)
Table 36. Anti-Peptic Ulcer Drugs Price by Type (2016-2021) & (USD/MT)
Table 37. Global Anti-Peptic Ulcer Drugs Price Forecast by Type (2022-2027) & (USD/MT)
Table 38. Global Anti-Peptic Ulcer Drugs Sales by Application (2016-2021) & (K MT)
Table 39. Global Anti-Peptic Ulcer Drugs Sales by Application (2022-2027) & (K MT)
Table 40. Global Anti-Peptic Ulcer Drugs Sales Share by Application (2016-2021)
Table 41. Global Anti-Peptic Ulcer Drugs Sales Share by Application (2022-2027)
Table 42. Global Anti-Peptic Ulcer Drugs Revenue by Application (2016-2021) & (US$ Million)
Table 43. Global Anti-Peptic Ulcer Drugs Revenue by Application (2022-2027) & (US$ Million)
Table 44. Global Anti-Peptic Ulcer Drugs Revenue Share by Application (2016-2021)
Table 45. Global Anti-Peptic Ulcer Drugs Revenue Share by Application (2022-2027)
Table 46. Anti-Peptic Ulcer Drugs Price by Application (2016-2021) & (USD/MT)
Table 47. Global Anti-Peptic Ulcer Drugs Price Forecast by Application (2022-2027) & (USD/MT)
Table 48. North America Anti-Peptic Ulcer Drugs Sales by Type (2016-2021) & (K MT)
Table 49. North America Anti-Peptic Ulcer Drugs Sales by Type (2022-2027) & (K MT)
Table 50. North America Anti-Peptic Ulcer Drugs Revenue by Type (2016-2021) & (US$ Million)
Table 51. North America Anti-Peptic Ulcer Drugs Revenue by Type (2022-2027) & (US$ Million)
Table 52. North America Anti-Peptic Ulcer Drugs Sales by Application (2016-2021) & (K MT)
Table 53. North America Anti-Peptic Ulcer Drugs Sales by Application (2022-2027) & (K MT)
Table 54. North America Anti-Peptic Ulcer Drugs Revenue by Application (2016-2021) & (US$ Million)
Table 55. North America Anti-Peptic Ulcer Drugs Revenue by Application (2022-2027) & (US$ Million)
Table 56. North America Anti-Peptic Ulcer Drugs Sales by Country (2016-2021) & (K MT)
Table 57. North America Anti-Peptic Ulcer Drugs Sales by Country (2022-2027) & (K MT)
Table 58. North America Anti-Peptic Ulcer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 59. North America Anti-Peptic Ulcer Drugs Revenue by Country (2022-2027) & (US$ Million)
Table 60. Europe Anti-Peptic Ulcer Drugs Sales by Type (2016-2021) & (K MT)
Table 61. Europe Anti-Peptic Ulcer Drugs Sales by Type (2022-2027) & (K MT)
Table 62. Europe Anti-Peptic Ulcer Drugs Revenue by Type (2016-2021) & (US$ Million)
Table 63. Europe Anti-Peptic Ulcer Drugs Revenue by Type (2022-2027) & (US$ Million)
Table 64. Europe Anti-Peptic Ulcer Drugs Sales by Application (2016-2021) & (K MT)
Table 65. Europe Anti-Peptic Ulcer Drugs Sales by Application (2022-2027) & (K MT)
Table 66. Europe Anti-Peptic Ulcer Drugs Revenue by Application (2016-2021) & (US$ Million)
Table 67. Europe Anti-Peptic Ulcer Drugs Revenue by Application (2022-2027) & (US$ Million)
Table 68. Europe Anti-Peptic Ulcer Drugs Sales by Country (2016-2021) & (K MT)
Table 69. Europe Anti-Peptic Ulcer Drugs Sales by Country (2022-2027) & (K MT)
Table 70. Europe Anti-Peptic Ulcer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 71. Europe Anti-Peptic Ulcer Drugs Revenue by Country (2022-2027) & (US$ Million)
Table 72. Asia Pacific Anti-Peptic Ulcer Drugs Sales by Type (2016-2021) & (K MT)
Table 73. Asia Pacific Anti-Peptic Ulcer Drugs Sales by Type (2022-2027) & (K MT)
Table 74. Asia Pacific Anti-Peptic Ulcer Drugs Revenue by Type (2016-2021) & (US$ Million)
Table 75. Asia Pacific Anti-Peptic Ulcer Drugs Revenue by Type (2022-2027) & (US$ Million)
Table 76. Asia Pacific Anti-Peptic Ulcer Drugs Sales by Application (2016-2021) & (K MT)
Table 77. Asia Pacific Anti-Peptic Ulcer Drugs Sales by Application (2022-2027) & (K MT)
Table 78. Asia Pacific Anti-Peptic Ulcer Drugs Revenue by Application (2016-2021) & (US$ Million)
Table 79. Asia Pacific Anti-Peptic Ulcer Drugs Revenue by Application (2022-2027) & (US$ Million)
Table 80. Asia Pacific Anti-Peptic Ulcer Drugs Sales by Region (2016-2021) & (K MT)
Table 81. Asia Pacific Anti-Peptic Ulcer Drugs Sales by Region (2022-2027) & (K MT)
Table 82. Asia Pacific Anti-Peptic Ulcer Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 83. Asia Pacific Anti-Peptic Ulcer Drugs Revenue by Region (2022-2027) & (US$ Million)
Table 84. Latin America Anti-Peptic Ulcer Drugs Sales by Type (2016-2021) & (K MT)
Table 85. Latin America Anti-Peptic Ulcer Drugs Sales by Type (2022-2027) & (K MT)
Table 86. Latin America Anti-Peptic Ulcer Drugs Revenue by Type (2016-2021) & (US$ Million)
Table 87. Latin America Anti-Peptic Ulcer Drugs Revenue by Type (2022-2027) & (US$ Million)
Table 88. Latin America Anti-Peptic Ulcer Drugs Sales by Application (2016-2021) & (K MT)
Table 89. Latin America Anti-Peptic Ulcer Drugs Sales by Application (2022-2027) & (K MT)
Table 90. Latin America Anti-Peptic Ulcer Drugs Revenue by Application (2016-2021) & (US$ Million)
Table 91. Latin America Anti-Peptic Ulcer Drugs Revenue by Application (2022-2027) & (US$ Million)
Table 92. Latin America Anti-Peptic Ulcer Drugs Sales by Country (2016-2021) & (K MT)
Table 93. Latin America Anti-Peptic Ulcer Drugs Sales by Country (2022-2027) & (K MT)
Table 94. Latin America Anti-Peptic Ulcer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 95. Latin America Anti-Peptic Ulcer Drugs Revenue by Country (2022-2027) & (US$ Million)
Table 96. Middle East and Africa Anti-Peptic Ulcer Drugs Sales by Type (2016-2021) & (K MT)
Table 97. Middle East and Africa Anti-Peptic Ulcer Drugs Sales by Type (2022-2027) & (K MT)
Table 98. Middle East and Africa Anti-Peptic Ulcer Drugs Revenue by Type (2016-2021) & (US$ Million)
Table 99. Middle East and Africa Anti-Peptic Ulcer Drugs Revenue by Type (2022-2027) & (US$ Million)
Table 100. Middle East and Africa Anti-Peptic Ulcer Drugs Sales by Application (2016-2021) & (K MT)
Table 101. Middle East and Africa Anti-Peptic Ulcer Drugs Sales by Application (2022-2027) & (K MT)
Table 102. Middle East and Africa Anti-Peptic Ulcer Drugs Revenue by Application (2016-2021) & (US$ Million)
Table 103. Middle East and Africa Anti-Peptic Ulcer Drugs Revenue by Application (2022-2027) & (US$ Million)
Table 104. Middle East and Africa Anti-Peptic Ulcer Drugs Sales by Country (2016-2021) & (K MT)
Table 105. Middle East and Africa Anti-Peptic Ulcer Drugs Sales by Country (2022-2027) & (K MT)
Table 106. Middle East and Africa Anti-Peptic Ulcer Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 107. Middle East and Africa Anti-Peptic Ulcer Drugs Revenue by Country (2022-2027) & (US$ Million)
Table 108. AstraZeneca Corporation Information
Table 109. AstraZeneca Description and Major Businesses
Table 110. AstraZeneca Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 111. AstraZeneca Anti-Peptic Ulcer Drugs Product
Table 112. AstraZeneca Recent Developments
Table 113. Ask-pharm Corporation Information
Table 114. Ask-pharm Description and Major Businesses
Table 115. Ask-pharm Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 116. Ask-pharm Anti-Peptic Ulcer Drugs Product
Table 117. Ask-pharm Recent Developments
Table 118. Takeda Corporation Information
Table 119. Takeda Description and Major Businesses
Table 120. Takeda Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 121. Takeda Anti-Peptic Ulcer Drugs Product
Table 122. Takeda Recent Developments
Table 123. Yangtze River Pharm Corporation Information
Table 124. Yangtze River Pharm Description and Major Businesses
Table 125. Yangtze River Pharm Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 126. Yangtze River Pharm Anti-Peptic Ulcer Drugs Product
Table 127. Yangtze River Pharm Recent Developments
Table 128. Shandong Luoxin Corporation Information
Table 129. Shandong Luoxin Description and Major Businesses
Table 130. Shandong Luoxin Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 131. Shandong Luoxin Anti-Peptic Ulcer Drugs Product
Table 132. Shandong Luoxin Recent Developments
Table 133. Huadong Medicine Corporation Information
Table 134. Huadong Medicine Description and Major Businesses
Table 135. Huadong Medicine Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 136. Huadong Medicine Anti-Peptic Ulcer Drugs Product
Table 137. Huadong Medicine Recent Developments
Table 138. Changzhou Siyao Corporation Information
Table 139. Changzhou Siyao Description and Major Businesses
Table 140. Changzhou Siyao Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 141. Changzhou Siyao Anti-Peptic Ulcer Drugs Product
Table 142. Changzhou Siyao Recent Developments
Table 143. Beijing Yuekang Corporation Information
Table 144. Beijing Yuekang Description and Major Businesses
Table 145. Beijing Yuekang Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 146. Beijing Yuekang Anti-Peptic Ulcer Drugs Product
Table 147. Beijing Yuekang Recent Developments
Table 148. Guangdong Dahua Corporation Information
Table 149. Guangdong Dahua Description and Major Businesses
Table 150. Guangdong Dahua Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 151. Guangdong Dahua Anti-Peptic Ulcer Drugs Product
Table 152. Guangdong Dahua Recent Developments
Table 153. Xian Janssen Corporation Information
Table 154. Xian Janssen Description and Major Businesses
Table 155. Xian Janssen Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 156. Xian Janssen Anti-Peptic Ulcer Drugs Product
Table 157. Xian Janssen Recent Developments
Table 158. Key Raw Materials Lists
Table 159. Raw Materials Key Suppliers Lists
Table 160. Anti-Peptic Ulcer Drugs Distributors List
Table 161. Anti-Peptic Ulcer Drugs Customers List
Table 162. Anti-Peptic Ulcer Drugs Market Trends
Table 163. Anti-Peptic Ulcer Drugs Market Drivers
Table 164. Anti-Peptic Ulcer Drugs Market Challenges
Table 165. Anti-Peptic Ulcer Drugs Market Restraints
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Peptic Ulcer Drugs Product Picture
Figure 2. Global Anti-Peptic Ulcer Drugs Market Share by Type in 2020 & 2027
Figure 3. Proton Pump Inhibitors (PPIs) Product Picture
Figure 4. Potassium-Competitive Acid Blockers (P-CAB) Product Picture
Figure 5. Antacids Product Picture
Figure 6. H2 Antagonists Product Picture
Figure 7. Ulcer Protective Drugs Product Picture
Figure 8. Global Anti-Peptic Ulcer Drugs Sales Market Share by Application in 2020 & 2027
Figure 9. Gastritis
Figure 10. Gastric Ulcers
Figure 11. Duodenal Ulcers
Figure 12. Gastroesophageal Reflux Disease (GERD)
Figure 13. Anti-Peptic Ulcer Drugs Report Years Considered
Figure 14. Global Anti-Peptic Ulcer Drugs Sales 2016-2027 (K MT)
Figure 15. Global Anti-Peptic Ulcer Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Anti-Peptic Ulcer Drugs Revenue 2016-2027 (US$ Million)
Figure 17. Global Anti-Peptic Ulcer Drugs Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 18. Global Anti-Peptic Ulcer Drugs Sales Market Share by Region (2016-2021)
Figure 19. Global Anti-Peptic Ulcer Drugs Sales Market Share by Region (2022-2027)
Figure 20. North America Anti-Peptic Ulcer Drugs Sales YoY (2016-2027) & (K MT)
Figure 21. North America Anti-Peptic Ulcer Drugs Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Europe Anti-Peptic Ulcer Drugs Sales YoY (2016-2027) & (K MT)
Figure 23. Europe Anti-Peptic Ulcer Drugs Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Asia-Pacific Anti-Peptic Ulcer Drugs Sales YoY (2016-2027) & (K MT)
Figure 25. Asia-Pacific Anti-Peptic Ulcer Drugs Revenue YoY (2016-2027) & (US$ Million)
Figure 26. Latin America Anti-Peptic Ulcer Drugs Sales YoY (2016-2027) & (K MT)
Figure 27. Latin America Anti-Peptic Ulcer Drugs Revenue YoY (2016-2027) & (US$ Million)
Figure 28. Middle East & Africa Anti-Peptic Ulcer Drugs Sales YoY (2016-2027) & (K MT)
Figure 29. Middle East & Africa Anti-Peptic Ulcer Drugs Revenue YoY (2016-2027) & (US$ Million)
Figure 30. The Top 10 and Top 5 Players Market Share by Anti-Peptic Ulcer Drugs Sales in 2020
Figure 31. The Top 10 and Top 5 Players Market Share by Anti-Peptic Ulcer Drugs Revenue in 2020
Figure 32. Anti-Peptic Ulcer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 33. Global Anti-Peptic Ulcer Drugs Sales Market Share by Type (2016-2027)
Figure 34. Global Anti-Peptic Ulcer Drugs Revenue Market Share by Type (2016-2027)
Figure 35. Global Anti-Peptic Ulcer Drugs Sales Market Share by Application (2016-2027)
Figure 36. Global Anti-Peptic Ulcer Drugs Revenue Market Share by Application (2016-2027)
Figure 37. North America Anti-Peptic Ulcer Drugs Sales Market Share by Type (2016-2027)
Figure 38. North America Anti-Peptic Ulcer Drugs Revenue Market Share by Type (2016-2027)
Figure 39. North America Anti-Peptic Ulcer Drugs Sales Market Share by Application (2016-2027)
Figure 40. North America Anti-Peptic Ulcer Drugs Revenue Market Share by Application (2016-2027)
Figure 41. North America Anti-Peptic Ulcer Drugs Sales Share by Country (2016-2027)
Figure 42. North America Anti-Peptic Ulcer Drugs Revenue Share by Country (2016-2027)
Figure 43. U.S. Anti-Peptic Ulcer Drugs Revenue (2016-2027) & (US$ Million)
Figure 44. Canada Anti-Peptic Ulcer Drugs Revenue (2016-2027) & (US$ Million)
Figure 45. Europe Anti-Peptic Ulcer Drugs Sales Market Share by Type (2016-2027)
Figure 46. Europe Anti-Peptic Ulcer Drugs Revenue Market Share by Type (2016-2027)
Figure 47. Europe Anti-Peptic Ulcer Drugs Sales Market Share by Application (2016-2027)
Figure 48. Europe Anti-Peptic Ulcer Drugs Revenue Market Share by Application (2016-2027)
Figure 49. Europe Anti-Peptic Ulcer Drugs Sales Share by Country (2016-2027)
Figure 50. Europe Anti-Peptic Ulcer Drugs Revenue Share by Country (2016-2027)
Figure 51. Germany Anti-Peptic Ulcer Drugs Revenue (2016-2027) & (US$ Million)
Figure 52. France Anti-Peptic Ulcer Drugs Revenue (2016-2027) & (US$ Million)
Figure 53. U.K. Anti-Peptic Ulcer Drugs Revenue (2016-2027) & (US$ Million)
Figure 54. Italy Anti-Peptic Ulcer Drugs Revenue (2016-2027) & (US$ Million)
Figure 55. Russia Anti-Peptic Ulcer Drugs Revenue (2016-2027) & (US$ Million)
Figure 56. Asia Pacific Anti-Peptic Ulcer Drugs Sales Market Share by Type (2016-2027)
Figure 57. Asia Pacific Anti-Peptic Ulcer Drugs Revenue Market Share by Type (2016-2027)
Figure 58. Asia Pacific Anti-Peptic Ulcer Drugs Sales Market Share by Application (2016-2027)
Figure 59. Asia Pacific Anti-Peptic Ulcer Drugs Revenue Market Share by Application (2016-2027)
Figure 60. Asia Pacific Anti-Peptic Ulcer Drugs Sales Share by Region (2016-2027)
Figure 61. Asia Pacific Anti-Peptic Ulcer Drugs Revenue Share by Region (2016-2027)
Figure 62. China Anti-Peptic Ulcer Drugs Revenue (2016-2027) & (US$ Million)
Figure 63. Japan Anti-Peptic Ulcer Drugs Revenue (2016-2027) &

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Anti-Peptic Ulcer Drugs Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110

According to our LPI (LP Information) latest study, the global Anti-Peptic Ulcer Drugs market size was valued at US$ 8523.5 million in 2023. With growing demand in downstream market, the Anti-Peptic Ulcer Drugs is forecast to a readjusted size of US$ 21200 million by 2030 with a CAGR of 13.9% during review period. The research report highlights the growth potential of the global Anti-Peptic Ulcer Drugs market. Anti-Peptic Ulcer Drugs are expected to show stable growth in the future marke......

Global Lansoprazole Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 102

The Lansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......

Global Irritable Bowel Syndrome (IBS) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88

According to our LPI (LP Information) latest study, the global Irritable Bowel Syndrome (IBS) market size was valued at US$ 4634.2 million in 2023. With growing demand in downstream market, the Irritable Bowel Syndrome (IBS) is forecast to a readjusted size of US$ 12750 million by 2030 with a CAGR of 15.6% during review period. The research report highlights the growth potential of the global Irritable Bowel Syndrome (IBS) market. Irritable Bowel Syndrome (IBS) are expected to show stabl......

Global Esomeprazole Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 89

The Esomeprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Esomeprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......

Global Irritable Bowel Syndrome (IBS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 126

Market Overview of Global Irritable Bowel Syndrome (IBS) market: According to our latest research, the global Irritable Bowel Syndrome (IBS) market looks promising in the next 5 years. As of 2022, the global Irritable Bowel Syndrome (IBS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive anal......

Global Diarrhea Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 109

Market Overview of Global Diarrhea Drug market: According to our latest research, the global Diarrhea Drug market looks promising in the next 5 years. As of 2022, the global Diarrhea Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Diarrhea Drug market, with a sys......

Drugs for Traveler's Diarrhea - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 96

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Drugs for Traveler's Diarrhea, with bo......

Global Lansoprazole Professional Survey Report 2023, Forecast to 2028

Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 136

Lansoprazole reduces the amount of acid your stomach makes. It's used for indigestion, heartburn and acid reflux and gastroesophageal-reflux-disease (GORD). Lansoprazole is also taken to prevent and treat stomach ulcers. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their g......

Global Pentasa (Ulcerative Colitis) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 113

Market Overview of Global Pentasa (Ulcerative Colitis) market: According to our latest research, the global Pentasa (Ulcerative Colitis) market looks promising in the next 5 years. As of 2022, the global Pentasa (Ulcerative Colitis) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis o......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs